.png)
Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage cervical carcinoma who have intermediate risk factors following radical hysterectomy, a phase 3 trial found. The current standard for women with early-stage disease and intermediate-risk factors is radiotherapy alone...
55W 14th St Ste 101, Helena, Montana, 59601, US
+1(406)-319-1601
news.in.usa@olahost.top
Copyright © 2024 olascience. All Rights Reserved
